Essential tremor in the older adult: coping with primary symptoms.
Luggen
Ann Schmidt
AS
Northern Kentucky University, Highland Heights, USA.
D000085:Acetates / Q000627:therapeutic use; D000223:Adaptation, Psychological; D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000368:Aged; D000525:Alprazolam / Q000627:therapeutic use; D000588:Amines; D000927:Anticonvulsants / Q000627:therapeutic use; D000978:Antiparkinson Agents / Q000627:therapeutic use; D019274:Botulinum Toxins, Type A / Q000627:therapeutic use; D003509:Cyclohexanecarboxylic Acids; D020329:Essential Tremor / Q000175:diagnosis / Q000188:drug therapy* / Q000503:physiopathology*; D018757:GABA Modulators / Q000627:therapeutic use; D000077206:Gabapentin; D006801:Humans; D009465:Neuromuscular Agents / Q000627:therapeutic use; D011324:Primidone / Q000627:therapeutic use; D011433:Propranolol / Q000627:therapeutic use; D012720:Severity of Illness Index; D005680:gamma-Aminobutyric Acid
D000085:Acetates; D000319:Adrenergic beta-Antagonists; D000588:Amines; D000927:Anticonvulsants; D000978:Antiparkinson Agents; D003509:Cyclohexanecarboxylic Acids; D018757:GABA Modulators; D009465:Neuromuscular Agents; D011324:Primidone; D005680:gamma-Aminobutyric Acid; D000077206:Gabapentin; D011433:Propranolol; D019274:Botulinum Toxins, Type A; D000525:Alprazolam